

The U.K.'s Medicines and Healthcare products Regulatory Agency approved Eisai and Biogen's Leqembi for treating mild cognitive impairment and mild dementia due...
You can purchase shares of EISAI CO LTD U/ADR by Eisai Co., Ltd. (OTCPK:ESAIY) through any online brokerage.
There are no as such competitors for EISAI CO LTD U/ADR by Eisai Co., Ltd..
There is no analysis for EISAI CO LTD U/ADR by Eisai Co., Ltd. to provide a consensus price target.
The stock price for EISAI CO LTD U/ADR by Eisai Co., Ltd. (OTCPK: ESAIY) is $7.52 last updated November 2, 2026 at 8:00 AM EST.
There are no upcoming dividends for EISAI CO LTD U/ADR by Eisai Co., Ltd..
EISAI CO LTD U/ADR by Eisai Co., Ltd. does not have any upcoming earnings scheduled.
There is no upcoming split for EISAI CO LTD U/ADR by Eisai Co., Ltd..
EISAI CO LTD U/ADR by Eisai Co., Ltd. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Eisai Co Ltd is a specialty and generic drug manufacturing company. The company's business consists of research and development, manufacturing, sales, import, and export of pharmaceuticals. The pharmaceutical business is categorized by region,...